Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
NU ›
NUDYN CP
Trademark search for:
NUDYN CP
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-12-07 — Application filed
2018-12-11 — Application filed
2018-12-31 — Application filed
2018-12-31 — Assigned to examiner
2018-12-31 — Final disposition recorded
2018-12-31 — Final disposition recorded
2018-12-31 — Final disposition recorded
2019-06-28 — Office action issued
2019-07-03 — Assigned to lie
2019-07-10 — Correspondence received in law office
2019-07-10 — Teas/email correspondence entered
2019-08-06 — Final disposition recorded
2019-08-06 — Final disposition recorded
2019-08-06 — Final disposition recorded
2020-02-04 — Office action issued
2020-02-04 — Correspondence received in law office
2020-02-05 — Teas/email correspondence entered
2020-02-28 — Approved for pub - principal register
2020-03-18 — Notification of notice of publication e-mailed
2020-04-07 — Published for opposition
2020-04-07 — Official gazette publication confirmation e-mailed
2020-06-02 — Noa e-mailed - sou required from applicant
2021-01-04 — Application abandoned
2021-01-04 — Application abandoned
2021-01-04 — Final status recorded
Owner Information
Fidia Farmaceutici S.p.A.
I-35031 Abano Terme IT
Fidia Farmaceutici S.p.A.
I-35031 Abano Terme IT
Correspondent
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C. 151 West 42nd Street, 17th Floor New York, NY 10036 UNITED STATES
Filing Details
Filing Date:
2018-12-07
Status Date:
2021-01-04
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.